These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23617802)

  • 1. Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.
    Zapparoli GV; Jorissen RN; Hewitt CA; McBean M; Westerman DA; Dobrovic A
    BMC Cancer; 2013 Apr; 13():206. PubMed ID: 23617802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel modi cation of real-time AS-qPCR by using locked nucleic acid-modified oligonucleotide probe as wild type allele amplification blockers for quantitative detection of the JAK2 V617F mutation].
    Shao DH; Liang GW; He ML; Cao QY
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):421-5. PubMed ID: 23688754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tetra-primer polymerase chain reaction approach for the detection of JAK2 V617F mutation.
    Koksal V; Etlik O; Arican-Baris ST; Baris I
    Genet Test; 2007; 11(4):463-6. PubMed ID: 18294066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR.
    Kinz E; Leiherer A; Lang AH; Drexel H; Muendlein A
    Int J Lab Hematol; 2015 Apr; 37(2):217-24. PubMed ID: 24963593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of a real-time PCR assay for quantification of JAK2 V617F and wild-type JAK2 transcript levels in the clinical laboratory.
    Merker JD; Jones CD; Oh ST; Schrijver I; Gotlib J; Zehnder JL
    J Mol Diagn; 2010 Jan; 12(1):58-64. PubMed ID: 19959796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR.
    Waterhouse M; Follo M; Pfeifer D; von Bubnoff N; Duyster J; Bertz H; Finke J
    Ann Hematol; 2016 Apr; 95(5):739-44. PubMed ID: 26931113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
    Di Francia R; Crisci S; Muto T; Giancola C; Petriccone L; Catapano O; Cummarro A; Pinto A; Frigeri F
    J Appl Lab Med; 2020 Jul; 5(4):643-655. PubMed ID: 32407536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly sensitive quantitative real-time PCR assay for determination of mutant JAK2 exon 12 allele burden.
    Kjær L; Westman M; Hasselbalch Riley C; Høgdall E; Weis Bjerrum O; Hasselbalch H
    PLoS One; 2012; 7(3):e33100. PubMed ID: 22403733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioluminometric assay for relative quantification of mutant allele burden: application to the oncogenic somatic point mutation JAK2 V617F.
    Tsiakalou V; Petropoulou M; Ioannou PC; Christopoulos TK; Kanavakis E; Anagnostopoulos NI; Savvidou I; Traeger-Synodinos J
    Anal Chem; 2009 Oct; 81(20):8596-602. PubMed ID: 19824717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].
    Chae H; Lee JH; Lim J; Jung SW; Kim M; Kim Y; Han K; Cho BS; Cho SG; Lee JW; Min WS
    Korean J Lab Med; 2009 Jun; 29(3):243-8. PubMed ID: 19571623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of acquired Janus kinase 2 V617F mutation in myeloproliferative disorders by fluorescence melting curve analysis.
    Reading NS; Lim MS; Elenitoba-Johnson KS
    Mol Diagn Ther; 2006; 10(5):311-7. PubMed ID: 17022694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting.
    Lin CY; Ho CM; Tamamyan G; Yang SF; Peng CT; Chang JG
    J Clin Lab Anal; 2016 Nov; 30(6):838-844. PubMed ID: 27169616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated JAK2V617F quantification using a magnetic filtration system and sequence-specific primer-single molecule fluorescence detection.
    Ohyashiki K; Hori K; Makino T; Ohyashiki JH
    Cancer Genet Cytogenet; 2007 Nov; 179(1):19-24. PubMed ID: 17981210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.
    Tan AY; Westerman DA; Dobrovic A
    Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.
    Jovanovic JV; Ivey A; Vannucchi AM; Lippert E; Oppliger Leibundgut E; Cassinat B; Pallisgaard N; Maroc N; Hermouet S; Nickless G; Guglielmelli P; van der Reijden BA; Jansen JH; Alpermann T; Schnittger S; Bench A; Tobal K; Wilkins B; Cuthill K; McLornan D; Yeoman K; Akiki S; Bryon J; Jeffries S; Jones A; Percy MJ; Schwemmers S; Gruender A; Kelley TW; Reading S; Pancrazzi A; McMullin MF; Pahl HL; Cross NC; Harrison CN; Prchal JT; Chomienne C; Kiladjian JJ; Barbui T; Grimwade D
    Leukemia; 2013 Oct; 27(10):2032-9. PubMed ID: 23860450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a tetra-primer amplification refractory mutation system-polymerase chain reaction combined with melting analysis-assay for clinical JAK2 V617F mutation detection.
    Liu W; Hu T; Chen Y; Zhang X; Gu X; Guan M
    Mol Diagn Ther; 2014 Oct; 18(5):579-85. PubMed ID: 25015634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection and quantification of the JAK2V617F allele by real-time PCR blocking wild-type amplification by using a peptide nucleic acid oligonucleotide.
    Huijsmans CJ; Poodt J; Savelkoul PH; Hermans MH
    J Mol Diagn; 2011 Sep; 13(5):558-64. PubMed ID: 21723417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera.
    Wu Z; Yuan H; Zhang X; Liu W; Xu J; Zhang W; Guan M
    PLoS One; 2011; 6(10):e26534. PubMed ID: 22028900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2V617F allele burden in patients with myeloproliferative neoplasms.
    Alshemmari SH; Rajaan R; Ameen R; Al-Drees MA; Almosailleakh MR
    Ann Hematol; 2014 May; 93(5):791-6. PubMed ID: 24362471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Establishment of a system for rapid detection of JAK2 V617F mutation in myeloproliferative diseases].
    Zhang Q; Zhang Y; Xu X; Zhou W; Fan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):980-984. PubMed ID: 31598940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.